Strategies for triggered drug release from tumor targeted liposomes.

Abstract:

INTRODUCTION:Long circulating liposomal drug carriers are widely used in experimental cancer therapy because they avoid excretion and benefit from the enhanced permeability and retention-effect to accumulate at the tumor site while simultaneously limiting systemic exposure to the cytotoxic drug due to their high stability. A drawback of the stability of the formulation is that the unloading of the drug at the target site is very poor. This opens up a new challenge to trigger drug release at the target site, while still retaining most of the drug inside the carrier while it resides in the bloodstream. AREAS COVERED:A short introduction is given about lipid polymorphism and phase behavior. To illustrate how this can be used to design triggered release systems, the development of delivery systems that are activated by tumor environment, UV or visible light and mild heat are discussed. The most recent triggered release systems have evolved even further, creating a need for more sophisticated triggers, which are as non-invasive and patient friendly as possible. EXPERT OPINION:Currently the most promising triggered release systems that have advanced furthest are thermosensitive liposomal delivery systems. As mild hyperthermia also increases tissue permeability it appears a suitable trigger for drug release while it also assists in drug accumulation. Combined with an advanced imaging system in the MR-high intensity focused ultrasound, this could be the combination of delivery system and trigger that can achieve clinical success.

journal_name

Expert Opin Drug Deliv

authors

Oude Blenke E,Mastrobattista E,Schiffelers RM

doi

10.1517/17425247.2013.805742

subject

Has Abstract

pub_date

2013-10-01 00:00:00

pages

1399-410

issue

10

eissn

1742-5247

issn

1744-7593

journal_volume

10

pub_type

杂志文章,评审
  • Controlled release using mesoporous materials containing gate-like scaffoldings.

    abstract::The use of gated mesoporous silica solids as suitable systems for controlled-release protocols is reviewed. These materials are based on mesoporous silica supports that can be prepared with tailor-made pores of around 2 - 10 nm and that show a very large specific surface area (up to 1200 m(2)/g), thus having a large l...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240902895980

    authors: Aznar E,Martínez-Máñez R,Sancenón F

    更新日期:2009-06-01 00:00:00

  • An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I.

    abstract:INTRODUCTION:Currently, hot melt extrusion (HME) is a promising technology in the pharmaceutical industry, as evidenced by its application to manufacture various FDA-approved commercial products in the market. HME is extensively researched for enhancing the solubility and bioavailability of poor water-soluble drugs, ta...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2019.1609448

    authors: Kallakunta VR,Sarabu S,Bandari S,Tiwari R,Patil H,Repka MA

    更新日期:2019-05-01 00:00:00

  • Preclinical models for pulmonary drug delivery.

    abstract:BACKGROUND:The lung comprises an interesting route of administration not only for topical drugs but also for systemically acting drugs. Over the last years, several models have been developed in order to study the efficacy and safety of pulmonary drug delivery. OBJECTIVE:This review describes relevant drug delivery mo...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903241788

    authors: Fernandes CA,Vanbever R

    更新日期:2009-11-01 00:00:00

  • Transarterial chemoembolization of hepatocellular carcinoma. Agents and drugs: an overview. Part 1.

    abstract:INTRODUCTION:Hepatocellular carcinoma (HCC) is one of the most common lethal malignancies. The prognosis is poor despite progress in early diagnosis. The initial treatment of choice is hepatic resection; unfortunately, not all patients are eligible for liver resection. Moreover, there are significant recurrences. Diffe...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.770733

    authors: Giunchedi P,Maestri M,Gavini E,Dionigi P,Rassu G

    更新日期:2013-05-01 00:00:00

  • Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach.

    abstract:IMPORTANCE OF THE FIELD:Efficient systemic delivery of low-molecular-mass therapeutics to neuronal tissue remains a central issue not only to drug development but also to the chronic treatment of a range of neurodegenerative disorders. AREAS COVERED IN THIS REVIEW:This review discusses the potential of using RNA inter...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2010.490554

    authors: Campbell M,Ozaki E,Humphries P

    更新日期:2010-07-01 00:00:00

  • Challenges in the pharmaceutical development of lipid-based short interfering ribonucleic acid therapeutics.

    abstract:INTRODUCTION:Harnessing RNA interference as a therapeutic approach has the potential to significantly expand the druggable target space, offering new hope for treatment of diseases that cannot be addressed with existing classes of drugs. A number of siRNA therapeutics have already progressed into preclinical and clinic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.642363

    authors: Gindy ME,Leone AM,Cunningham JJ

    更新日期:2012-02-01 00:00:00

  • Design and in vitro release study of siRNA loaded Layer by Layer nanoparticles with sustained gene silencing effect.

    abstract:OBJECTIVES:Clinical translation of siRNA therapeutics has been severely limited due to the lack of stable and sustained siRNA delivery systems. Furthermore, when nanocarrier systems with siRNA are administered systemically to treat diseases, insufficient doses reach the target tissue. Here we report the successful deve...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2018.1518426

    authors: Tan YF,Lee YS,Seet LF,Ng KW,Wong TT,Venkatraman S

    更新日期:2018-10-01 00:00:00

  • Progressive stent technologies: new approaches for the treatment of cardiovascular diseases.

    abstract::The CYPHER (Cordis, Johnson & Johnson) sirolimus-eluting stent and the TAXU (Boston Scientific) paclitaxel-eluting stent have been extensively evaluated and have been proven to be significant novel tools for the treatment of coronary artery disease. Several sirolimus derivatives have already emerged, receiving CE Mark...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.3.6.783

    authors: Vaina S,Serruys PW

    更新日期:2006-11-01 00:00:00

  • Nanostructured hyaluronic acid-based materials for active delivery to cancer.

    abstract:IMPORTANCE OF THE FIELD:Active targeting of bioactive molecules by physicochemical association with hyaluronic acid (HA) is an attractive approach in current nanomedicine because HA is biocompatible, non-toxic and non-inflammatory. AREAS COVERED IN THIS REVIEW:This review focuses on synthesis, physicochemical characte...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425241003730399

    authors: Ossipov DA

    更新日期:2010-06-01 00:00:00

  • Bacteriophages as vehicles for gene delivery into mammalian cells: prospects and problems.

    abstract:INTRODUCTION:The identification of more efficient gene delivery vehicles (GDVs) is essential to fulfill the expectations of clinical gene therapy. Bacteriophages, due to their excellent safety profile, extreme stability under a variety of harsh environmental conditions and the capability for being genetically manipulat...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.927437

    authors: Bakhshinejad B,Sadeghizadeh M

    更新日期:2014-10-01 00:00:00

  • Harnessing CD47 mimicry to inhibit phagocytic clearance and enhance anti-tumor efficacy of nanoliposomal doxorubicin.

    abstract:BACKGROUND:We hypothesized if phagocytosis of liposomes by macrophages could be mitigated through incorporation of a CD47 mimicry peptide (Self peptide: SP) on the surface of liposomes. METHODS:Thin film hydration method followed by extrusion was used to prepare nanoliposomes, and Dox encapsulation in liposomes was do...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1772749

    authors: Gheibi Hayat SM,Jaafari MR,Hatamipour M,Jamialahmadi T,Sahebkar A

    更新日期:2020-07-01 00:00:00

  • Drug, delivery and devices for diabetic retinopathy (3Ds in DR).

    abstract:INTRODUCTION:Diabetic Retinopathy (DR) is one of the most common causes of blindness among the working population worldwide. Clearly, there is an unmet clinical need to find better treatment options for DR. Areas covered: The literature search was conducted on PubMed with no limitation on language or year of publicatio...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1188800

    authors: Nirmal J,Radhakrishnan K,Moreno M,Natarajan JV,Laude A,Lim TH,Venkatraman S,Agrawal R

    更新日期:2016-11-01 00:00:00

  • Polymer-drug conjugates: recent progress on administration routes.

    abstract:INTRODUCTION:Polymer-drug conjugates are an important part of polymer therapeutics. Recently, they have been used as an appealing platform for drug delivery. As a delivery vector, the route of administration performs a serious impact on the accessibility of drug molecules to their respective target site and therapeutic...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.912779

    authors: Pang X,Yang X,Zhai G

    更新日期:2014-07-01 00:00:00

  • Recent advances in polymeric microspheres for parenteral drug delivery--part 1.

    abstract:INTRODUCTION:Polymeric microspheres have been established as a valuable parenteral drug delivery system for sustained release of therapeutic agents via subcutaneous or intramuscular injection. AREAS COVERED:Biodegradable polymers which are either synthetic or from natural sources are reviewed with respect to recent ad...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2012.709844

    authors: Mao S,Guo C,Shi Y,Li LC

    更新日期:2012-09-01 00:00:00

  • The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior.

    abstract:INTRODUCTION:Plasma protein binding with nanoparticles (NPs) occurs immediately upon their introduction into a physiological environment and is affected by the characteristics of NPs, including their composition, size, shape and surface properties. According to their specific functions, adsorbed proteins can be divided...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.877442

    authors: Gao H,He Q

    更新日期:2014-03-01 00:00:00

  • Tailoring antibodies for radionuclide delivery.

    abstract::Therapeutic antibodies are well established as an important class of drugs in modern medicine. The exquisite specificity and affinity for a specific target offered by antibodies has also encouraged their development as delivery vehicles for agents such as radionuclides to target tissues, for radioimmunoimaging and rad...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.3.1.53

    authors: Kenanova V,Wu AM

    更新日期:2006-01-01 00:00:00

  • Drug delivery to the lymphatic system: importance in future cancer diagnosis and therapies.

    abstract::Cancer is the second leading cause of death in the US. Currently, protocols for cancer treatment include surgery to remove diseased and suspect tissues, focused radiation, systemic chemotherapy, immunotherapy and their combinations. With conventional chemotherapy, it is almost impossible to deliver anticancer drugs sp...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903085128

    authors: Xie Y,Bagby TR,Cohen MS,Forrest ML

    更新日期:2009-08-01 00:00:00

  • Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.

    abstract:INTRODUCTION:For poorly soluble compounds, a good bioavailability is typically needed to assess the therapeutic index and the suitability of the compound for technical development. In industry, the selection of the delivery technology is not only driven by technical targets, but also by constraints, such as production ...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2011.614228

    authors: van Hoogevest P,Liu X,Fahr A

    更新日期:2011-11-01 00:00:00

  • Thermoresponsive polymers as gene and drug delivery vectors: architecture and mechanism of action.

    abstract:INTRODUCTION:This topic is important as it allows for improved specificity in drug delivery, providing possibilities for reduced side effects, and thereby improved pharmacotherapy. As a wealth of different polymers and mechanisms of action has been suggested, a systematic overview of the field is of current importance....

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.846906

    authors: Calejo MT,Sande SA,Nyström B

    更新日期:2013-12-01 00:00:00

  • Current status of non-viral gene therapy for CNS disorders.

    abstract:INTRODUCTION:Viral and non-viral vectors have been used as methods of delivery in gene therapy for many CNS diseases. Currently, viral vectors such as adeno-associated viruses (AAV), retroviruses, lentiviruses, adenoviruses and herpes simplex viruses (HHV) are being used as successful vectors in gene therapy at clinica...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1188802

    authors: Jayant RD,Sosa D,Kaushik A,Atluri V,Vashist A,Tomitaka A,Nair M

    更新日期:2016-10-01 00:00:00

  • Advances in ocular drug delivery: emphasis on the posterior segment.

    abstract:INTRODUCTION:Recent advances in pharmacological therapies to treat ocular diseases such as glaucoma, age-related macular degeneration, diabetic macular edema and retinal vascular occlusions have greatly improved the prognosis for these diseases. Due to these advances in pharmacological therapy, there is a great deal of...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.935338

    authors: Kang-Mieler JJ,Osswald CR,Mieler WF

    更新日期:2014-10-01 00:00:00

  • Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades.

    abstract:BACKGROUND:Therapeutic peptides have great potential as anticancer agents owing to their ease of rational design and target specificity. However, their utility in vivo is limited by low stability and poor tumor penetration. OBJECTIVE:The authors review the development of peptide inhibitors with potential for cancer th...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240903143745

    authors: Bidwell GL 3rd,Raucher D

    更新日期:2009-10-01 00:00:00

  • Enteric-coated alendronate sodium nanoliposomes: a novel formula to overcome barriers for the treatment of osteoporosis.

    abstract:BACKGROUND AND OBJECTIVES:Alendronate sodium (ALS) is the most common drug used for the treatment of osteoporosis. The challenges facing ALS use include: very poor oral bioavailability (0.6%), esophageal ulcers, and complicated instructions for its use. The objective of this research is to utilize nanotechnology to for...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1517/17425247.2013.799136

    authors: Hosny KM,Ahmed OA,Al-Abdali RT

    更新日期:2013-06-01 00:00:00

  • The perspectives of intra-articular therapy in the management of osteoarthritis.

    abstract:INTRODUCTION:Management of Osteoarthritis (OA) still is a challenge for clinicians. Taking into account a multidisciplinary approach including pharmacological and non-pharmacological treatments, intra-articular (IA) injection could be considered as an effective local therapy. Areas covered This review provides a new pe...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2020.1783234

    authors: Migliore A,Paoletta M,Moretti A,Liguori S,Iolascon G

    更新日期:2020-09-01 00:00:00

  • Antibiotic uptake through porins located in the outer membrane of Gram-negative bacteria.

    abstract::Introduction: Making selective inhibitors of novel Gram-negative targets is not a substantial challenge - getting them into Gram-negative bacteria to reach their lethal target is the bottleneck. Poor permeability of the antibiotic requires high concentration causing off target activity. The lack of simple experimental...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2021.1847080

    authors: Winterhalter M

    更新日期:2020-11-13 00:00:00

  • Measurement and prediction of the rate and extent of drug delivery into and through the skin.

    abstract::Skin diseases are prevalent and can significantly affect quality of life. Empirical mathematical models retrospectively analyse data to predict skin permeation from the physico-chemical properties of drugs. Quantitative structure permeability relationships are discussed, along with alternatives to linear modelling. Me...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425240902865561

    authors: Russell LM,Guy RH

    更新日期:2009-04-01 00:00:00

  • Evaluation of chamomile oil and nanoemulgels as a promising treatment option for atopic dermatitis induced in rats.

    abstract::Background: Atopic dermatitis is a chronic inflammatory skin disease that remarkably affects the quality-of-life of patients. Chamomile oil is used to treat skin inflammations. We evaluated the efficacy of chamomile oil and nanoemulgel formulations as a natural alternative therapeutic option for atopic dermatitis.Rese...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章

    doi:10.1080/17425247.2020.1699054

    authors: El-Salamouni NS,Ali MM,Abdelhady SA,Kandil LS,Elbatouti GA,Farid RM

    更新日期:2020-01-01 00:00:00

  • Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release.

    abstract:INTRODUCTION:Polymers can be designed to modify their features as a function of the level and nature of the surrounding microorganisms. Such responsive polymers can endow drug delivery systems and drug-medical device combination products with improved performance against intracellular infections and biofilms. AREAS CO...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1080/17425247.2016.1178719

    authors: Alvarez-Lorenzo C,Garcia-Gonzalez CA,Bucio E,Concheiro A

    更新日期:2016-08-01 00:00:00

  • Cutaneous immunization: an evolving paradigm in influenza vaccines.

    abstract:INTRODUCTION:Most vaccines are administered by intramuscular injection using a hypodermic needle and syringe. Some limitations of this procedure include reluctance to be immunized because of fear of needlesticks, and concerns associated with the safe disposal of needles after their use. Skin delivery is an alternate ro...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2014.885947

    authors: Gill HS,Kang SM,Quan FS,Compans RW

    更新日期:2014-04-01 00:00:00

  • Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications.

    abstract:INTRODUCTION:Peptide and protein microarray and microneedle array technology provides direct information on protein function and potential drug targets in drug discovery and delivery. Because of this unique ability, these arrays are well suited for protein profiling, drug target identification/validation and studies of...

    journal_title:Expert opinion on drug delivery

    pub_type: 杂志文章,评审

    doi:10.1517/17425247.2013.797405

    authors: Chandrasekhar S,Iyer LK,Panchal JP,Topp EM,Cannon JB,Ranade VV

    更新日期:2013-08-01 00:00:00